📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes. (2021)

First Author: Kim A

Attributed to: The role of impaired glucagon secretion in life-threatening hypoglycaemia of type 1 diabetes: mechanism and therapeutic potential funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.72919

PubMed Identifier: 34787082

Publication URI: http://europepmc.org/abstract/MED/34787082

Type: Journal Article/Review

Volume: 10

Parent Publication: eLife

ISSN: 2050-084X